Nebraska Medicine

Oncology Service Line Cancer treatment services offered by the corporation include treatment of lymphoma, leukemia, multiple myeloma, head and neck, breast, gastrointestinal, pancreatic, lung, genitourinary prostate, gynecologic, melanoma, brain, and spine cancers. The patients are supported by research that is conducted on the University of Nebraska Medical Center (UNMC) campus. The Nebraska Medical Center (TNMC) is the only clinical cancer center in its service area designated by the national cancer institute. In addition to treatment and clinical trials, TNMC offers support groups, social work, pain management, financial counselors, survivorship groups, genetic counseling, and a variety of additional patient supportive services. In June 2017, TNMC opened the Fred and Pamela Buffett Cancer Center. The center is jointly owned with UNMC, and it is one of the foremost cancer research and treatment facilities in the country. It is the site of inpatient hospital care, as well as outpatient and diagnostic care. UNMC's facilities, within the center, house research labs. TNMC operates cancer treatment locations in Bellevue, NE; West Omaha, NE; and in Shenandoah, IA. In addition, as one of the busiest programs in the world, the bone marrow transplantation program served 227 patients in the year ended June 30, 2022. A 24/7 emergency and evaluation treatment center are dedicated to cancer and transplants. The program benefits from the research conducted on TNMC/UNMC campuses. TNMC was one of the first cancer centers in the nation to participate in clinical trials for CAR-T cell therapy. It was FDA-Approved in October 2017. The therapy treatment was extended to leukemia patients in 2018 and multiple myeloma patients in 2019. During fiscal year 2022, the oncology service line treated 133,989 cases.

Heart and Vascular Service Line The Nebraska Medical Center (TNMC) provides a wide range of cardiovascular services from diet counseling to surgical procedures and rehabilitation to patients from the surrounding region. TNMC has grown into one of the busiest centers in the country for ventricular assist device operations. TNMC has been successful in recruiting physicians and has the only heart failure specialist in the region, and the only heart failure program certified by the joint commission in the State of Nebraska. In 2016, TNMC began a lung transplant program, and in December 2017, TNMC performed the state's first heart and lung transplant. In the year ended June 30, 2022, TNMC performed 13 lung transplants. The congestive heart failure program and acute myocardial infarction program each received the gold seal of approval certification from the American Heart Association. This program is certified by the joint commission, and these services are the only nationally certified programs of their kind in the State of Nebraska. The chest pain center has received full chest pain center accreditation from the Society of Chest Pain Centers. TNMC has been recognized for service excellence under the J.D. Power and Associates Distinguished Hospital Program. TNMC has the only joint commission certified destination therapy program in the state and is the only hospital in the region performing adult heart transplants and implanting total artificial hearts. In the year ended June 30, 2022, 827 open heart surgeries were performed, including 43 heart transplants.

Neurological Sciences Service Line The core services include precise diagnosis and treatment of stroke and vascular disease, movement and memory disorders, multiple sclerosis brain and spinal tumors, spine as well as epilepsy. The epilepsy center is the only level four center in the region and treats patients from the State of Nebraska and surrounding region. The Nebraska Medical Center (TNMC) has one of the few magnetoencephalography (MEG) scanners and trained MEG scientists in the region. The MEG can detect brain activity in much greater detail and with more accuracy than previous methods and advances patient care and research opportunities. In July 2018, TNMC opened the Twin Creek Health Center, a dedicated neurological sciences ambulatory clinic in Bellevue, NE. TNMC has earned the American Heart Association/American Stroke Association's Get with the Guidelines Stroke Gold Plus Achievement Award. Get with the Guidelines is a hospital-based, quality-improvement program designed to ensure hospitals consistently care for cardiac and stroke patients following the most up-to-date guidelines and recommendations. TNMC also hosts the only young adult stroke support group to address the emotion and physical challenges of recovering from stroke.

All Other Hospital Services WITH A HISTORY DATING BACK TO 1869, TNMC WAS FORMED WITH THE MERGING OF BISHOP CLARKSON MEMORIAL HOSPITAL AND UNIVERSITY HOSPITAL. IN JULY 2016, UNMC PHYSICIANS OUTPATIENT CLINICS BECAME PART OF THE ORGANIZATION. TNMC CONTINUES TO ATTRACT PATIENTS FROM THE REGION AND AROUND THE WORLD. TNMC IS A TERTIARY/QUATERNARY ACADEMIC MEDICAL CENTER. IT IS THE LARGEST HEALTH CARE FACILITY IN THE STATE WITH MORE THAN 10,000 EMPLOYEES AND OVER 700 PHYSICIANS PRACTICING IN ALL MAJOR SPECIALTIES AND SUB-SPECIALTIES. IN ADDTION TO KEY SERVICES IN CARDIOLOGY, ONCOLOGY, TRANSPLANT AND NEUROLOGY, TNMC OFFERS COMPREHENSIVE CARE IN WOMEN'S SERVICES FOR OBSTETRICS AND GYNECOLOGY, AS WELL AS PEDIATRIC SERVICES, ORTHOPEDICS, RHEUMATOLOGY, AND PULMONARY CARE. IN ADDITION, TNMC HAS ONE OF THE REGION'S LARGEST HYPERBARIC MEDICINE PROGRAMS. TNMC IS THE MOST ESTEEMED ACADEMIC HEALTH SYSTEMS IN THE REGION, WITH 809 LICENSED BEDS AT ITS TWO HOSPITALS, NEBRASKA MEDICAL CENTER AND BELLEVUE MEDICAL CENTER. TNMC ALSO OPERATES 40 SPECIALTY AND PRIMARY CARE CLINICS IN OMAHA AND SURROUNDING AREAS. TNMC HAS ONE OF THE FEW BIOCONTAINMENT UNITS IN THE UNITED STATES EQUIPPED TO SAFELY CARE FOR PEOPLE EXPOSED TO HIGHLY CONTAGIOUS, DANGEROUS DISEASES. IN 2014, THE NEBRASKA BIOCONTAINMENT UNIT WAS ACTIVATED TO PROVIDE CARE FOR THREE AMERICANS WHO CONTRACTED THE EBOLA VIRUS DURING THE WEST AFRICA OUTBREAK. THIS RESPONSE RESULTED IN TNMC AND UNMC BECOMING ONE OF THREE DESIGNATED EBOLA TREATMENT AND EDUCATION CENTERS IN THE UNITED STATES. THROUGHOUT THE LAST DECADE, BIOCONTAINMENT UNIT STAFF HAVE CONTINUED TO EDUCATE PUBLIC HEALTH AND INFECTIOUS DISEASE TEAMS FROM AROUND THE WORLD ABOUT SAFE PROTOCOLS AND RESPONSES TO INFECTIOUS DISEASES, MOST RECENTLY COVID-19. TNMC WAS ONE OF THE FIRST TO CARE FOR EXPOSED AND INFECTED AMERICANS IN EARLY 2020 AND CONTINUES TO BE A WORLD LEADER IN TREATING AND MITIGATING THE VIRUS MORE THAN TWO YEARS INTO THE PANDEMIC. THE ORGANIZATION CONTINUES TO STRIVE TOWARD ITS MISSION TO LEAD THE WORLD IN TRANSFORMING LIVES TO CREATE A HEALTHY FUTURE FOR ALL INDIVIDUALS AND COMMUNITIES THROUGH PREMIER EDUCATIONAL PROGRAMS, INNOVATIVE RESEARCH AND EXTRAORDINARY PATIENT CARE. THIS WAS DEMONSTRATED THROUGH A VARIETY OF ACTIVITIES THROUGHOUT FY22 AS WELL AS THE HEALTH SYSTEM MAINTAINING ITS ROLE AS A LOCAL, REGIONAL AND NATIONAL LEADER IN THE RESPONSE TO THE COVID-19 PANDEMIC. THE FOLLOWING EFFORTS CONTINUED AS A RESULT OF THE COVID-19 PANDEMIC: * INPATIENT AND OUTPATIENT CLINICAL CARE FOR PATIENTS AFFECTED BY COVID-19 * UNIVERSAL MASKING AND PERSONAL PROTECTIVE EQUIPMENT POLICIES FOR STAFF AND PATIENTS * CONTINUED TO REQUIRE COVID-19 VACCINATION FOR STAFF * CONDUCTED OUTREACH AND PROVIDED MONOCLONAL ANTIBODY INFUSIONS TO PATIENTS INFECTED WITH COVID-19 AT HIGHEST RISK OF SERIOUS DISEASE OR COMPLICATIONS * UTILIIZATION OF E-VISITS AND VIDEO VISITS THROUGH AN ONLINE PATIENT PORTAL AND PATIENT-FACING MOBILE APP. ALLOWED FOR INCREASED ACCESS AND INCLUDES PRIMARY, SPECIALTY AND IMMEDIATE CARE APPOINTMENTS * CREATION OF TRAINING MATERIALS THROUGH THE GLOBAL CENTER FOR HEALTH SECURITY * PROVIDED TRAINING AND EDUCATION FOR HEALTH CARE WORKERS THROUGH NATIONAL EMERGING SPECIAL PATHOGENS TRAINING AND EDUCATION (NETEC) * CONDUCTED AND PARTICIPATED IN CLINICAL TRIALS * SERVED AS A COMMUNITY AND NATIONAL EXPERT THROUGH NEWS AND SOCIAL MEDIA, AND COMMUNITY OUTREACH ADDITIONAL HIGHLIGHTS FROM THE YEAR INCLUDED * ACQUIRED HEARTLAND HEMATOLOGY & ONCOLOGY IN KEARNEY, NEBRASKA. * BEGAN CONSTRUCTION OF PHARMACY HUB IN OMAHA TO IMPROVE EFFICIENCY OF DISTRIBUTION OF PRESCRIPTIONS TO NEBRASKA MEDICINE'S RETAIL PHARMACY LOCATIONS * EXPANSION OF THE OFFICE OF INCLUSION AND DIVERSITY, HIRING NEW DEPARTMENT STAFF AND EXPANDING THE NUMBER AND SCOPE OF EMPLOYEE RESOURCE GROUPS * CONTINUING CONSTRUCTION OF CLINICAL FACILITIES AT VILLAGE POINTE HEALTH CENTER IN WEST OMAHA, INCREASING SERVICES AND ACCESS FOR PATIENTS * EXPANSION OF FAST PASS PROGRAM, WHICH ALLOWS PATIENTS TO BE NOTIFIED OF APPOINTMENT CANCELLATIONS AND BE SEEN BY PROVIDERS AS OPENINGS ARE AVAILABLE * CONSTRUCTION AND ONGOING DESIGN FOR INNOVATION DESIGN UNIT, A PATIENT CARE UNIT THAT WILL BE USED TO PILOT INNOVATIVE CARE DELIVERY AND TECHNOLOGY IN FY22, NEBRASKA MEDICAL CENTER EARNED THE FOLLOWING: * NAMED BEST HOSPITAL IN NEBRASKA BY U.S. NEWS AND WORLD REPORT FOR THE 11TH CONSECUTIVE YEAR * NAMED ONE OF THE TOP TEN TRUSTED HEALTH SYSTEMS BY THE AMERICAN HOSPTIAL ASSOCIATION * NAMED AS ONE OF NEWSWEEK'S WORLD'S BEST HOSPITALS 2022 * NAMED AS ONE OF NEWSWEEK'S BEST MATERNITY HOSPITALS 2022 * NAMED AS ONE OF NEWSWEEK'S BEST SMART HOSPTIALS 2022 * RECOGNIZED BY FORBES AS ONE OF THE TOP TEN BEST EMPLOYERS IN NEBRSAKA FOR THE FOURTH CONSECUTIVE YEAR * TRAINING MAGAZINE'S TOP 100 COMPANIES FOR TRAINING PROGRAMS AWARD

Digestive Disease and Kidney Service Line The Nebraska Medical Center (TNMC) operates one of the busiest solid organ transplant programs in the world. In 2016, TNMC joined a small number of transplant centers which have programs for transplants of all solid organs. TNMC's lung transplant program did its first transplant in February 2016, and 13 lung transplants were performed during 2022. In the year ended June 30, 2022, TNMC performed 295 solid organ transplants including liver, kidney, heart, lung, pancreas, and small bowel. The success of TNMC's solid organ transplant program is heightened by research done on the TNMC/University of Nebraska Medical Center (UNMC) campuses. Since its inception, patients have come to TNMC for single or multiple organ transplants from all fifty states and five continents.